Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis (Q33857658)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Arturo Casadevall

5

object named as

Arturo Casadevall

1 reference

Europe PubMed Central

29 July 2017

3

object named as

John Perfect

1 reference

Europe PubMed Central

29 July 2017

8

object named as

Scott Filler

1 reference

Europe PubMed Central

29 July 2017

4

object named as

Judith A Aberg

1 reference

Europe PubMed Central

29 July 2017

Peter G. Pappas

2

object named as

Peter G Pappas

1 reference

Europe PubMed Central

29 July 2017

author name string

Robert A Larsen

1

1 reference

Europe PubMed Central

29 July 2017

Gretchen A Cloud

6

1 reference

Europe PubMed Central

29 July 2017

Robert James

7

1 reference

Europe PubMed Central

29 July 2017

William E Dismukes

9

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

29 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

29 July 2017

49

1 reference

Europe PubMed Central

29 July 2017

3

1 reference

Europe PubMed Central

29 July 2017

952-958

1 reference

Europe PubMed Central

29 July 2017

Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

THE FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. III. EXTRACELLULAR SPREAD OF CRYPTOCOCCAL POLYSACCHARIDES IN THE ACUTE STAGE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Immunoregulation by capsular components of Cryptococcus neoformans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Early mycological treatment failure in AIDS-associated cryptococcal meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Human immune response to monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Protective murine monoclonal antibodies to Cryptococcus neoformans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Complement depletion in cryptococcal sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. VI. INTRACELLULAR ACCUMULATION OF FLUID AND CRYPTOCOCCAL POLYSACCHARIDE IN OLIGODENDROGLIA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. V. TRANSFER OF FLUID FROM EXTRACELLULAR TO INTRACELLULAR COMPARTMENTS IN ACUTE PHASE OF CRYPTOCOCCAL POLYSACCHARIDE LESIONS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum therapy for Cryptococcal meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SERUM PROTEIN ENHANCEMENT OF ANTIBIOTIC THERAPY IN CRYPTOCOCCOSIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotype can affect the fine specificity of an antibody for a polysaccharide antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive immunization in murine cryptococcosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.3.952-958.2005

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33857658&oldid=1777325600"